Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Luetkemeyer et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaf029
https://c19early.org/luetkemeyer.html